Most of the first-generation MMP inhibitors were designed as collagen-mimicking peptides containing the collagen aminoacid sequence near the collagenase cleavage site, combined with a zinc-binding hydroxamate moiety to inhibit enzymatic activity
Most of the first-generation MMP inhibitors were designed as collagen-mimicking peptides containing the collagen aminoacid sequence near the collagenase cleavage site, combined with a zinc-binding hydroxamate moiety to inhibit enzymatic activity